Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial

已完结 10 由 bobobo 发布于 2026/2/6 10:25:29

DOI:10.1038/s41591-025-03899-x
作者：Xiaobing Wang,?Yi Zhang,?Huimin Wang,?Xin Wu,?Chao He,?Suxian Lin,?Kun Pang,?Yang Li,?Yue Chen,?Xiaojing Tang,?Xin Liu,?Jiazheng Wang,?Songying Ye,?Ran Yan,?Tongxiang Guan,?Bing Dai,?Jing Lu,?Haiyan H
文献类型：期刊论文
补充材料：只需要正文

Nature

Abstract：Commercial autologous anti-CD19 chimeric antigen receptor-T cell therapies are effective in B cell malignancies and autoimmune diseases but are limited by personalized manufacturing, high co

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierThe role of different Wx and BEIIb allele combinations on fine structures and functional properties of indica rice starches